我国药品现代物流发展的不足与应对策略思考  

The shortcomings and countermeasures of the development of modern drug logistics in China

作　　者：侯玉磊 李海峰 张娇 田宝坤 HOU Yulei;LI Haifeng;ZHANG Jiao;TIAN Baokun(Shandong Center for Food and Drug Evaluation&Inspection,Ji’nan 250014,China)

机构地区：[1]山东省食品药品审评查验中心,济南250014

出　　处：《上海医药》2024年第13期62-65,75,共5页Shanghai Medical & Pharmaceutical Journal

摘　　要：本文简要分析了药品现代物流企业与传统药品经营企业的区别和药品现代物流的优势,指出了当下我国药品现代物流发展的不足,并就应对策略进行了深入思考与分析,以期为药品现代物流企业的发展和监管部门监管工作的开展提供借鉴思路。This article briefly analyzes the differences between modern drug logistics enterprises and traditional drug trading enterprises and the advantages of modern drug logistics,points out the shortcomings of the development of modern drug logistics in China at present,and carries out in-depth thinking and analysis of coping strategies,which provides a reference idea for the development of modern drug logistics enterprises and the supervisory work of the regulatory authorities.

关 键 词：药品现代物流 优势 不足 应对策略 

分 类 号：F715.1[经济管理—产业经济]